BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3079324)

  • 1. Update on the antitumor activity of alpha interferon.
    Quesda JR
    Oncology (Williston Park); 1988 Mar; 2(3):49-54. PubMed ID: 3079324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotherapy with interferon--1988.
    Figlin RA
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotherapy in clinical practice.
    Figlin RA
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons in oncology.
    Woll PJ; Pettengell R
    Br J Clin Pract; 1997 Mar; 51(2):111-5. PubMed ID: 9158255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
    Foon KA; Bunn PA
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of interferon on various malignancies].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of interferons in the treatment of cancer.
    Hansen RM; Borden EC
    Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic response modifiers: the interferon alfa experience.
    Koeller JM
    Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S11-5. PubMed ID: 2481396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W; Gastl G; Troppmair J; Tilg H; Abbrederis K; Nerl C; Flener R; Rokos H; Huber C
    Acta Med Austriaca; 1985; 12(5):115-21. PubMed ID: 3832745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of recombinant human interferon-alpha A/D on the growth of experimental tumors in mice].
    Ootsu K; Kozai Y; Houkan T; Gotoh K; Matsutani E
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2502-8. PubMed ID: 3304169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of renal cell carcinoma. 3. Interferon therapy].
    Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
    Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
    Kirkwood JM; Harris JE; Vera R; Sandler S; Fischer DS; Khandekar J; Ernstoff MS; Gordon L; Lutes R; Bonomi P
    Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of recombinant alpha-interferon on advanced renal cell carcinoma].
    Isaka S; Okano T; Akimoto S; Shimazaki J; Murakami S; Igarashi T; Kitamura Y; Yamaguchi K; Kataumi S; Ohtsuka K
    Hinyokika Kiyo; 1985 Dec; 31(12):2209-14. PubMed ID: 3832921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha interferons--new therapeutic modalities].
    Bajcetić M; Zigon N; Samardzić R; Beleslin DB
    Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Introduction of natural interferon-alpha "Sumiferon"].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2800-3. PubMed ID: 3631977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferons, interleukin-2 and tumor necrosis factor. New approaches to cancer therapy].
    Oettgen HF
    Arzneimittelforschung; 1987 Feb; 37(2A):251-5. PubMed ID: 2436634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.
    Mirro J; Dow LW; Kalwinsky DK; Dahl GV; Weck P; Whisnant J; Murphy SB
    Cancer Treat Rep; 1986 Mar; 70(3):363-7. PubMed ID: 3456833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.